Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolò Baldini Rossi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Dialogues in Clinical Neuroscience|October 29, 2011
Psychopharmacology of anxiety disordersGiovanni B Cassano, Nicolò Baldini Rossi, Stefano Pini
The Journal of Clinical Psychiatry|November 26, 2002
Nefazodone treatment of pathological gambling: a prospective open-label controlled trialStefano Pallanti, Nicolò Baldini Rossi, Erica Sood, et al.
The International Journal of Neuropsychopharmacology|November 8, 2003
Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled studyEric Hollander, Nicolò Baldini Rossi, Erica Sood, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 15, 2005
Imaging monetary reward in pathological gamblersEric Hollander, Stefano Pallanti, Nicolò Baldini Rossi, et al.
International Clinical Psychopharmacology|December 20, 2002
Treatment of depression with comorbid anxiety disorders: differential efficacy of paroxetine versus moclobemideStefano Pini, Xavier F Amador, Liliana Dell'Osso, et al.
Neuropsychobiology|May 19, 2006
Positron emission tomography imaging of risperidone augmentation in serotonin reuptake inhibitor-refractory patientsMonte S Buchsbaum, Eric Hollander, Stefano Pallanti, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Dialogues in Clinical Neuroscience|October 29, 2011
Psychopharmacology of anxiety disordersGiovanni B Cassano, Nicolò Baldini Rossi, Stefano Pini
The Journal of Clinical Psychiatry|November 26, 2002
Nefazodone treatment of pathological gambling: a prospective open-label controlled trialStefano Pallanti, Nicolò Baldini Rossi, Erica Sood, et al.
The International Journal of Neuropsychopharmacology|November 8, 2003
Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled studyEric Hollander, Nicolò Baldini Rossi, Erica Sood, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 15, 2005
Imaging monetary reward in pathological gamblersEric Hollander, Stefano Pallanti, Nicolò Baldini Rossi, et al.
International Clinical Psychopharmacology|December 20, 2002
Treatment of depression with comorbid anxiety disorders: differential efficacy of paroxetine versus moclobemideStefano Pini, Xavier F Amador, Liliana Dell'Osso, et al.
Neuropsychobiology|May 19, 2006
Positron emission tomography imaging of risperidone augmentation in serotonin reuptake inhibitor-refractory patientsMonte S Buchsbaum, Eric Hollander, Stefano Pallanti, et al.
Pageof 1